1


Report to the
GAVI Alliance Board

Board -2011 -Mtg -2-Doc 06
7-8 July 2011
Subject : India: Request for extension of deadline for
pentavalent vaccine support
Report of: Mercy Ahun, Managing Director Programme Delivery
Authored by: Ranjana Kumar, Senior Specialist Programme Delivery
Agenda item : 06
Category: For Decision
Strategic goal : SG 1 ? Underused and new vaccines


Section A: Overview

1. Purpose of the repor t

1.1. To seek Board consideration of India?s request for an extension to the deadline
to submit scaling up plans for the introduction of pentavalent vaccine from 30
June 2011 until 31 December 2011 .


2. Recommendations

2.1. The Secretariat recommends that the GAVI Alliance Board approve the
following resolution:

?The GAVI Alliance Board:

Noted the request by the Government of India to extend the period as set
by the Executive Committee to submit a satisfactory plan to introduce
DTP -HepB -Hib in additional states (the ?Introduction Plan?) from 30 June
2011 until 31 December 201 1; and

Decided to extend the deadline for the Government of India to submit the
Introduction Plan to a date to be agreed by the PPC -appointed Task
Team on L arge Countries (India and Nigeria) , enabling the Task Team to
take the Introduction Plan into account in its recommendation s to the
Board at its next meeting in November 2011. The remaining US$
118,500,000 of the NVS programme budget as endorsed by the
Executive Committee will be rescinded if the I ntroduction Plan is not
submitted by the agreed date and in any event no later than the
November Board meeting.?

1


Report to the
GAVI Alliance Board

Board -2011 -Mtg -2-Doc 07
7-8 July 2011
Subject : Accelerated Vaccine Introduction ? progress report
Report of: Nina Schwalbe, MD, Policy and Performance
Authored by: Jon Pearman, Director of Accelerated Vaccine
Introduction (AVI) Initiative
Agenda item : 07
Category: For Discussion
Strategic goal: SG1 - Vaccines and SG4 - Market shaping


Section A: Overview


1. Purpose of the report

1.1 To provide a summary on the progress of the Accelerated Vaccine Introduction
(AVI) initiative and to review ongoing challenges to building a successful
platform for future introduction of new vaccines.


2. Recommendations

2.1 The Board is recommended to take note of this report, in particular the
following:

(a) GAVI had an excellent start of its pneumococcal (pneumo) vaccine roll out
under AVI. Since manufacturers signed initial supply agreements under the
Advance Market Commitment (AMC) last year, pneumo vaccines have
been shipped to twelve countries on three continents. Vaccine supply is
tight but we are confident that we can meet the needs of 19 approved
countries. Beyond this, as anticipated, additional supply contracts are
needed.

(b) Rotavirus (rota) vaccine implementation outside of Latin America is
scheduled to start in 2011 and accelerate i n 2012.

(c) In May 2011, GAVI received a record number of 75 new applications for
new vaccines 1 from 50 countries.

1 Pneumo conjugate vaccine (PCV), rotavirus, meningitis A, yellow fever (YF), Haemophilus influenzae type B
vaccine (HiB) and measles 2nd dose vaccines.

1


Report to the
GAVI Alliance Board

Board -2011 -Mtg -2-Doc 08
7-8 July 2011
Subject : Cash Based Support
Report of: Nina Schwalbe, MD, Policy and Performance
Authored by: Par Eriksson, Senior Programme Officer,
Programme Delivery
Agenda item : 08
Category: For Decision
Strategic goal : SG2 - Health systems to deliver immunisation


Section A: Overview


1. Purpose of the repor t

1.1 The purpose of this report is to seek endorsement of the GAVI Alliance Board
for the Programme and Policy Committee (PPC) recommendations as
described below including the bridging mechanisms for HSS, ISS and CSOs
proposed in this report .


2. Recommendations

2.1 It is recommended that the GAVI Alliance Board adopt the following resolution:

The GAVI Alliance Board resolved to:

Request the Secretariat to continue working with partners to rollout the Health
Systems Funding Platform (the ?Platform?) in a manner which ensures that the
immunisation outcomes are clearly articulated in accordance with country
demand, including assessing and addressing associated risks;

Request the Secretariat to develop options for performance incentives for
GAVI?s cash based support through the Platform in coordination with the
design of the Incentives for Routine Immunisation Strengthening (I RIS) pilot;

Request countries and their partners to carry out an analysis to establish the
main reasons why countries have DTP3 coverage rates below 70 percent; why
some countries have coverage rates stagnating at low level; and why some
countries have s een significant declines in coverage over time. The aim of this

1


Report to the
GAVI Alliance Board

Board -2011 -Mtg -2-Doc 09
7-8 July 2011
Subject : Cash Programme Risk Management
Report of: Cees Klumper, Director of Internal Audit
Authored by: Cees Klumper
Agenda item : 09
Category: For Decision
Strategic goal : SG2 - Health systems to deliver immunisation


Section A: Overview


1. Purpose of the repor t

1.1 To present for the Board's consideration and decision Internal Audit's
recommendations on further strengthening GAVI's management of fiduciary
risk in its cash -support programmes . These recommendations reflect an
evolution rather than a revolution in GAVI's approach and have been designed
to achieve a level of risk management that is ?leading practice? in preventing,
detecting and responding to possi ble misuse of GAVI funds, reflecting GAVI?s
?zero -tolerance? policy towards such misuse.


2. Recommendations

2.1 The Internal Auditor recommends that the GAVI Alliance Board adopt the
following resolutions:

The GAVI Alliance Board resolved to :

Request the Secretariat to more actively engage Country Responsible Officers
(?CROs?) 1 in the area of fiduciary risk, including, through more frequent visits to
implementing countries;

Request the Secretariat to engage in more frequent review and follow -up of
programme reporting through its CROs and the Transparency and
Accountability Policy (?TAP?) Team;

1 CROs are the Secretariat?s ?interface? with implementing countries and maintain regular contact with
government, CSO and other Alliance partner representatives in -country, among other duties.

1


Report to the
Governance Committee

Board -2011 -Mtg -2-Doc 12a
Subject : Extra n ominations from the Governance
Committee
Report of: Debbie Adams, MD, Law and Governance
Authored by: Kevin A. Klock, Head of Governance & Assistant
Secretary
Agenda item : 12a (additional nominations)
Strategic goal : Alliance operations


Section A: Overview

1. Purpose of the repor t

1.1 The report informs the Board of the Governance Committee?s
recommendations for Board and committee membership , including
nominations received this week .

1.2 Assuming the Board appoints all persons that have been presented to the
Governance Committee this year, the Board would comply with the
gender balance guidelines for Board alternates.


2. Recommendations

2.1 The Governance Committee recommended the following persons for
appointment to the Board:

(a) Alan Hinman as Board Member representing civil society
organisations in the seat currently occupied by Faruque Ahmed
effective immediately and until 31 July 201 3.

(b) Joan Awunyo -Akaba as Alternate Board Member to Alan Hinman
representing civil society organisations in the seat currently occupied
by Alan Hinman effective immediately and until 31 July 201 3.

(c) Nila Heredia Miranda as Alternate Board Member to Guillermo
Jos? Gonz?lez Gonz?lez representing developing country
governments effective immediately and until 31 Dece mber 2012.

2.2 The Governance Committee recommended the following persons for
appointment to committees:
Report to the
GAVI Alliance Board
7-8 July 2011

1


Report to the
Governance Committee

Board -2011 -Mtg -2-Doc 12a
Subject : Nominations from the Governance Committee
Report of: Debbie Adams, MD, Law and Governance
Authored by: Kevin A. Klock, Corporate Gov ernance Officer &
Assistant Secretary
Agenda item : 12a
Strategic goal : Alliance operations


Section A: Overview

1. Purpose of the repor t

1.1 The report informs the Board of the Governance Committee?s
recommendations for Board and committee membership.


2. Recommendations

2.1 At its meeting on 23 March 201 1, the Governance Committee made the
following recommendations to the Board for the appointment of :

(a) Ronald Brus as Board Member representing the industrialised
country vaccine industry in the seat currently occupied by Jean
St?phenne effective immediately and until 31 July 2014.

(b) Olga Popova as Alternate Board Member representing the
industrialised country vaccine industry in the seat currently occupied
by Sian Clayden effective immediately and until 31 July 2014.

(c) Mahima Dat la as Board Member representing the developing
country vaccine industry in the seat currently occupied by Suresh
Jadhav effective immediately and until 31 July 2014.

2.2 Further, at its meeting on 23 March 2011, the Governance Committee
made the following rec ommendations for the appointment to the
committees of :

(a) Suresh Jadhav as Committee Delegate of the developing country
vaccine industry to the Programme and Policy Committee effective
immediately and until the committees are refreshed for the 2012
year.
Report to the
GAVI Alliance Board
7-8 July 2011

1


Report to the
GAVI Alliance Board

Board -2011 -Mtg -2-Doc 12c
7-8 July 2011
Subject : Delegation of Authority Policy
Report of: Debbie Adams, MD, Law and Governance
Authored by: Ruth Khalastchi, Senior Specialist, Corporate Policies
Agenda item : 12c
Strategic goal : Alliance operations

Section A: Overview

1. Purpose of the repor t

1.1 The purpose of the report is to provide an overview of recommended
amendments to the Delegation of Authority Policy.

2. Recommendations

2.1 It is recommended that the GAVI Alliance Board approve the following
resolution:

?The GAVI Alliance Board:

Approved the GAVI Alliance Delegation of Authority Policy attached as Annex
1 to the report on the Revision to the Delegation of Authority Policy, Doc #12c
replacing the Delegation of Authority Policy the Board had approved in June
2009. ?

3. Executive summary

3.1 The Board approved the Delegation of Authority Policy on 2-3 June 2009 . This
policy is attached as Annex 2. As part of its review of all policies, the
Secretariat would l ike to request amendments to this policy in the form of an
amended Delegation of Authority Policy . The principal amendments are as
follows:

(a) To provide the same powers of delegated authority to the Deputy Chief
Executive Officer as those currently delegated to the Officers of the GAVI
Alliance.

(b) To more closely align the standing delegations with the current practice of
the Secretariat . In pa rticular, the ? Expenditure ? section recognises the
transition from the workplan to the integrated business plan.

1


Report to the
GAVI Alliance Board

Board -2011 -Mtg -2-Doc 12d
7-8 July 2011
Subject : Revision to the Programme Funding Policy
Report of: Barry Greene, MD, Finance and Operations
Authored by: Barry Greene
Agenda item : 12d
Category: For Decision
Strategic goal : SG3 - Financing


Section A: Overview


1. Purpose of the repor t

1.1 Th is report proposes to join the programme funding system that the Board
adopted in June 2010 and the cash reserve requirement adopted by the Board
in November 2009 into the GAVI Programme Funding Policy . Th e proposed
Programme Funding Policy is in Appendix A (Revis ed GAVI Programme
Fund ing Policy ).


2. Recommendations

2.1 The Audit and Finance Committee (AFC) recommended that the GAVI Alliance
Board approve the revis ed GAVI Programme Funding P olicy and adopt the
following resolution:

The GAVI Alliance Board resolved to :

Approve the revised GAVI Programme Funding Policy attached as Appendix A
to the report on the Revision to the Pr ogramme Funding Policy, Doc # 12d .


3. Executive summary

3.1 In November 2009, the GAVI Alliance Board adopted a cash reserve
requirement under which the amount of cash and investments should always
equate to at least 8 months? projected cash outflows. In June 2010, the Board
adopted a system that requires that whe never the Board is considering the
approval or endorsement of funding for new programmes, as a prerequisite to
such approval or endorsement an amount of qualifying resources be set aside

1


Report to the
GAVI Al liance Board

Board -2011 -Mtg -2-Doc 12e
7-8 July 2011
Subject : Revision t o Cash Investment Policy
Report of: Barry Greene, MD, Finance and Operations
Authored by: Jeanne Shen , Senior Director, Investments
Agenda item : 12e
Category: For Decision
Strategic goal : Alliance operations


Section A: Overview


1. Purpose of the repor t

1.1 The purpose of this Report is to present a revised Cash and Short -Term
Investments Policy (?Policy?) to replace the existing Cash In vestment Policy
approved in June 2009 . The proposed P olicy expand s the investment options
and g uidelines to include short -term investments for cash pools .


2. Recommendations

2.1 The Investment Committee recommends that the GAVI Alliance Board
approve the revised Cash and Short -Term Investments Policy and adopt the
following resolution :

The GAVI Alliance Board:

Approves the Cash and Short -Term Investments Policy attached as Appendix
A to the report on the Revision to the Cash Investment Policy, Doc #12e.


3. Executive summary

3.1 The GAVI Alliance Board approved the current Cash Investment Policy in June
2009. The permitted in vestments according to that policy include money
market funds and bank deposits .

3.2 The GAVI Alliance Secretariat receives donor contributions on an ongoing
basis. Most of these funds are subsequently transferred to a vaccine
pr ocurement account when UNICEF places orders for GAVI -supported
vaccines, and held in that ?Procurement Account? until paid to UNICEF when
the vaccine payment becomes due some months later . Prior to being

1


Report to the
GAVI Alliance Board

Board -2011 -Mtg -2-Doc 14
7-8 July 2011
Subject : Update on performance and risk management
Report of: Helen Evans, Interim CEO
Authored by:
Nina Schwalbe, MD Policy and Performance;
Adrien de Chaisemartin, Head of Performance
Management;
Agenda item : 14
Category: For Information
Strategic goal : Alliance operations


Section A: Overview

1. Purpose of the repor t

1.1 This is the first report to update the Board on the performance management
process that was put in place at the beginning of 2011 for the implementation of the
GAVI Alliance Strategy 2011 -2015. It describes the quarterly reporting process and
management review conducted at the end of the first quarter of the year.


2. Recommendations

2.1 The Board is invited to comment on the performance management process put into
place and take note of the progress reports available on the MyGAVI site i.


3. Executive Summary

3.1 In support of GAVI?s mission to save children?s lives and protect people?s health by
increasing access to health in poor countries , the Board approved a strategy for
2011 -2015 which is underpinned by 4 strategic goals ( ?Vaccine ?, ?Health System?,
?Financing? and ?Market Shaping?) and cross cutting initiatives for Monitoring and
Evaluation and Advocacy Communication and Public Policy. The strategy is
implemented through the business plan, which defines activities in support of
strategic and programme objectives. The business plan also assigns responsibility
for delivery at the level of programme objective s in order to improve accountability
and drive for results.

3.2 Implementation of the business plan is managed through three key activities, all
conducted on a quarterly basis :

1


Report to the
GAVI Alliance Board

Board -2011 -Mtg -2-Doc 15
7-8 July 2011
Subject : Annual i nternal audit report
Report of: Cees Klumper, Director of Internal Audit
Authored by: Cees Klumper
Agenda item : 15
Category: For Information
Strategic goal : Alliance operations


Section A: Overview

1. Purpose of the repor t

1.1 To inform the Board about Internal Audit's first year -and -a-half of operations
since inception in November 2009 .

2. Recommendations

2.2 This report does not contain any recommendations for the Board. It is for
information only.

3. Executive summary

3.1 Internal Audit ('IA') has settled in well within the Secretariat. Working
relationships are good and recommendations are generally followed up with
sufficient priority.

3.2 IA reports to both the CEO and the Board. In IA?s view, so far, this reporting
arrangement has worked well and has not led to an impairment of the
function?s independence.

3.3 The current staffing level (one FTE) is deemed to be sufficient to be able to
effectiv ely carry out IA's mandate. This is reviewed on an ongoing basis .
Furthermore, the Board?s decision (pursuant to agenda item #09 ?Cash
Programme Risk Management?) is being sought as to whether the
Transparency and Accountability Policy team (?TAP?) , that c urrently reports to
Internal Audit on an interim basis, will be placed within Internal Audit
permanently . Should the Board approve this recommendation, then Internal
Audit?s headcount would increase to 6 FTE as TAP currently has an approved
headcount of 5 F TE .

Board Decisions
GAVI Alliance Board Meeting
Geneva, 7 -8 July 2011
GAVI Alliance Board meeting
7-8 July 2011
Decision 1: India ? Request for extension of
deadline for a scale up and expansion plan for
pentavalent support
The GAVI Alliance Board:
? Noted the request by the Government of India to extend the period
as set by the Executive Committee to submit a satisfactory plan to
introduce DTP -HepB -Hib in additional states (the ?Introduction
Plan?) from 30 June 2011 until 31 December 2011;
? Decided to extend the deadline for the Government of India to
submit the Introduction Plan to a date to be agreed by the PPC -
appointed Task Team on Large Countries (India and Nigeria),
enabling the Task Team to take the Introduction Plan into account in
its recommendations to the Board at its next meeting in November
2011; and
? Requested the Secretariat to develop a policy on time limits for the
commencement of approved programmes in country, including
principles for handling exceptions, and present it to the Board for
consideration at its meeting in November 2011.
1